LD 605 LR 1638(01)
An Act To Support Evidence-based Treatment for Opioid Use Disorder
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Vachon of Scarborough
Committee: Health and Human Services
Fiscal Note Required: Yes
Preliminary Fiscal Impact Statement
FY 2017-18 FY 2018-19 Projections  FY 2019-20 Projections  FY 2020-21
Net Cost (Savings)
General Fund $6,663,000 $6,663,000 $6,663,000 $6,663,000
General Fund $6,663,000 $6,663,000 $6,663,000 $6,663,000
Fiscal Detail and Notes
The bill includes General Fund appropriations to the Department of Health and Human Services of $6,663,000 beginning in fiscal year 2017-18 for primary care patient-centered medical homes and behavioral health providers that provide evidence-based, integrated medication-assisted treatment to patients with opioid use disorder to cover costs of intensive, intermediate and long-term treatment, including, but not limited to, the cost of medication, screening, behavioral health treatment and office visits for 1,000 uninsured patients.

A more current estimate, which includes an estimate for each individual service required by the bill, would increase the appropriation to the Department of Health and Human Services in fiscal year 2017-18 and fiscal year 2018-19 by $5,359,440 to $12,022,440.